Literature DB >> 19254785

Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells.

Sun Wook Cho1, Jae-Yeon Yang, Hyun Jin Sun, Ju Yeon Jung, Sun Ju Her, Hwa Young Cho, Hyung Jin Choi, Sang Wan Kim, Seong Yeon Kim, Chan Soo Shin.   

Abstract

Wnt inhibitory factor (WIF)-1 belongs to the members of secreted modulators of Wnt proteins. Secreted frizzled-related proteins (sFRPs), another member of Wnt modulators, have been shown to play differential roles in Wnt signaling depending on the subtypes and cell models. This study was undertaken to investigate the functional role of WIF-1 in osteoblastic differentiation of mouse mesenchymal C3H10T1/2 cells. C3H10T1/2 cells express endogenous WIF-1 and its expression level decreases during osteoblastogenesis. Treatment of C3H10T1/2 cells with WIF-1 significantly reduced alkaline phosphatase (ALP) activities induced by either osteogenic medium (OM, ascorbic acid and beta-glycerophosphate) or Wnt-3a conditioned medium (CM) in a dose-dependent manner. In contrast, the expression level of endogenous WIF-1 increased during adipogenesis and WIF-1 treatment resulted in increased adipogenesis. C3H10T1/2 cells transduced with WIF-1 retrovirus also exhibited reduced ALP activity and decreased mRNA expression of Runx2, collagen type 1, ALP and osteocalcin during osteoblastic differentiation compared to empty virus-transduced cells. Moreover, treatment with WIF-1 dose-dependently attenuates beta-catenin/T-cell factor (TCF) transcriptional activity in this cell line. Finally, knockdown of WIF-1 in C3H10T1/2 cells by RNA interference leads to increase in ALP activities. Collectively, these results indicate that WIF-1 plays as a negative regulator of osteoblastic differentiation in mouse mesenchymal C3H10T1/2 cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254785     DOI: 10.1016/j.bone.2009.02.012

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  24 in total

1.  The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer.

Authors:  Zhijun Shen; Chen Chen; Jianhai Sun; Jingsong Huang; Shiguo Liu
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-26       Impact factor: 4.553

2.  Identification and characterization of an injury-induced skeletal progenitor.

Authors:  Owen Marecic; Ruth Tevlin; Adrian McArdle; Eun Young Seo; Taylor Wearda; Christopher Duldulao; Graham G Walmsley; Allison Nguyen; Irving L Weissman; Charles K F Chan; Michael T Longaker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

Review 3.  Emerging therapeutic opportunities for skeletal restoration.

Authors:  Masanobu Kawai; Ulrike I Mödder; Sundeep Khosla; Clifford J Rosen
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 4.  Targeting CSC-related miRNAs for cancer therapy by natural agents.

Authors:  Bin Bao; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Ginny Bao; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

Review 5.  Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation.

Authors:  Grace L Lin; Kurt D Hankenson
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

6.  MicroRNA-140 promotes adipocyte lineage commitment of C3H10T1/2 pluripotent stem cells via targeting osteopetrosis-associated transmembrane protein 1.

Authors:  Yuan Liu; Zhi-chun Zhang; Shu-wen Qian; You-you Zhang; Hai-yan Huang; Yan Tang; Liang Guo; Xi Li; Qi-Qun Tang
Journal:  J Biol Chem       Date:  2013-02-06       Impact factor: 5.157

Review 7.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

8.  The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.

Authors:  David S Yee; Yaxiong Tang; Xuesen Li; Zhongbo Liu; Yi Guo; Samia Ghaffar; Peter McQueen; Dash Atreya; Jun Xie; Anne R Simoneau; Bang H Hoang; Xiaolin Zi
Journal:  Mol Cancer       Date:  2010-06-23       Impact factor: 27.401

9.  Inhibition of Wnt/β-catenin signaling by dexamethasone promotes adipocyte differentiation in mesenchymal progenitor cells, ROB-C26.

Authors:  Masako Naito; Kazuki Omoteyama; Yoshikazu Mikami; Tomihisa Takahashi; Minoru Takagi
Journal:  Histochem Cell Biol       Date:  2012-08-11       Impact factor: 4.304

10.  Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells.

Authors:  Luis A Solchaga; Kitsie Penick; Victor M Goldberg; Arnold I Caplan; Jean F Welter
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.